What does MEDI - PREST do?

MEDI - PREST is a pharmacy in Enghien. Public Limited, started on 29 July 1991, 1 establishment.

What is the address of MEDI - PREST?

The registered office of MEDI - PREST is located at Brusselsesteenweg(P.E.) 343, 7850 Enghien.

Is MEDI - PREST still active?

Yes. According to the CBE (29 October 2026) MEDI - PREST is active, legal situation “Normale toestand”, started on 29 July 1991.

Is MEDI - PREST registered on Peppol?

Yes, MEDI - PREST is registered on the Peppol network with ID 0208:0444790728.

What is the enterprise number of MEDI - PREST?

The enterprise number of MEDI - PREST is BE0444790728.

When was MEDI - PREST founded?

MEDI - PREST was founded on 29 July 1991.

Who are the directors of MEDI - PREST?

According to the 2025 annual accounts, the directors of MEDI - PREST are: ADV PHARMA SRL, CAROLINE DE VRIESE.

Is MEDI - PREST a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 July 1991; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did MEDI - PREST make in 2025?

MEDI - PREST posted a profit after taxes of € 163,021 in financial year 2025.

What is the revenue of MEDI - PREST?

As a small company, MEDI - PREST is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 526,296.

How much does an employee at MEDI - PREST earn?

The average wage cost per full-time employee at MEDI - PREST was € 64,200 in 2025: staff costs of € 205,406 for 3.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does MEDI - PREST have?

According to the 2025 annual accounts, MEDI - PREST has 3.2 full-time equivalents (FTE).

MEDI - PREST (Public Limited) - Enghien - BE0444790728

Dossier MEDI - PREST, printed on 29 October 2026 from databakkes.be/en/0444790728/medi-prest. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 54 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

MEDI - PREST from Enghien, company number BE0444790728, closed financial year 2025 with a result of € 163,021 after tax. For that financial year MEDI - PREST recorded a gross margin of € 526,296 and equity of € 240,528. Compared with financial year 2024, the result moved from € 169,697 to € 163,021. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.

What it is worth Growing

€ 240,528

▲ 36% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 163,021

▼ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 302,559

▲ 117% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 100,000 paid out

61 % of the profit went to the shareholders, mostly to ADV Pharma (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

3.2

▼ 0.3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 205,406

▼ 5% vs 2024

€ 64,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 38,686

▼ 11% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 707,923

▼ 12% vs 2024

€ 107,086 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 156,236

▲ 9% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 31,232

▼ 15% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 566,574 Gross margin 2022: € 566,574 First fiscal year in the series	€ 603,753 Gross margin 2023: € 603,753 ▲ 7% vs 2022 (€ 566,574) Favourable step	€ 546,294 Gross margin 2024: € 546,294 ▼ 10% vs 2023 (€ 603,753) Unfavourable step	€ 526,296 Gross margin 2025: € 526,296 ▼ 4% vs 2024 (€ 546,294) Unfavourable step	▼ 4%
Profit after taxes	€ 202,485 Profit after taxes 2022: € 202,485 First fiscal year in the series	€ 246,638 Profit after taxes 2023: € 246,638 ▲ 22% vs 2022 (€ 202,485) Favourable step	€ 169,697 Profit after taxes 2024: € 169,697 ▼ 31% vs 2023 (€ 246,638) Unfavourable step	€ 163,021 Profit after taxes 2025: € 163,021 ▼ 4% vs 2024 (€ 169,697) Unfavourable step	▼ 4%
Equity	€ 201,172 Equity 2022: € 201,172 First fiscal year in the series	€ 207,810 Equity 2023: € 207,810 ▲ 3% vs 2022 (€ 201,172) Favourable step	€ 177,506 Equity 2024: € 177,506 ▼ 15% vs 2023 (€ 207,810) Unfavourable step	€ 240,528 Equity 2025: € 240,528 ▲ 36% vs 2024 (€ 177,506) Favourable step	▲ 36%
Total debts	€ 1,603,607 Total debts 2022: € 1,603,607 First fiscal year in the series	€ 1,523,835 Total debts 2023: € 1,523,835 ▼ 5% vs 2022 (€ 1,603,607) Favourable step	€ 1,471,349 Total debts 2024: € 1,471,349 ▼ 3% vs 2023 (€ 1,523,835) Favourable step	€ 1,451,973 Total debts 2025: € 1,451,973 ▼ 1% vs 2024 (€ 1,471,349) Favourable step	▼ 1%
Cash	€ 200,023 Cash 2022: € 200,023 First fiscal year in the series	€ 126,244 Cash 2023: € 126,244 ▼ 37% vs 2022 (€ 200,023) Unfavourable step	€ 139,683 Cash 2024: € 139,683 ▲ 11% vs 2023 (€ 126,244) Favourable step	€ 302,559 Cash 2025: € 302,559 ▲ 117% vs 2024 (€ 139,683) Favourable step	▲ 117%
Land & buildings	€ 197,213 Land & buildings 2022: € 197,213 First fiscal year in the series	€ 175,317 Land & buildings 2023: € 175,317 ▼ 11% vs 2022 (€ 197,213) Unchanged	€ 153,421 Land & buildings 2024: € 153,421 ▼ 12% vs 2023 (€ 175,317) Unchanged	€ 131,525 Land & buildings 2025: € 131,525 ▼ 14% vs 2024 (€ 153,421) Unchanged	▼ 14%
Retained profit	€ 70,172 Retained profit 2022: € 70,172 First fiscal year in the series	€ 76,810 Retained profit 2023: € 76,810 ▲ 9% vs 2022 (€ 70,172) Favourable step	€ 46,506 Retained profit 2024: € 46,506 ▼ 39% vs 2023 (€ 76,810) Unfavourable step	€ 109,528 Retained profit 2025: € 109,528 ▲ 136% vs 2024 (€ 46,506) Favourable step	▲ 136%
Dividend	€ 240,000 Dividend 2022: € 240,000 First fiscal year in the series	€ 240,000 Dividend 2023: € 240,000 Unchanged (€ 240,000) Unchanged	€ 200,000 Dividend 2024: € 200,000 ▼ 17% vs 2023 (€ 240,000) Unchanged	€ 100,000 Dividend 2025: € 100,000 ▼ 50% vs 2024 (€ 200,000) Unchanged	▼ 50%
Bank debt	€ 939,382 Bank debt 2022: € 939,382 First fiscal year in the series	€ 873,255 Bank debt 2023: € 873,255 ▼ 7% vs 2022 (€ 939,382) Favourable step	€ 806,613 Bank debt 2024: € 806,613 ▼ 8% vs 2023 (€ 873,255) Favourable step	€ 707,923 Bank debt 2025: € 707,923 ▼ 12% vs 2024 (€ 806,613) Favourable step	▼ 12%
Balance sheet total	€ 1,804,779 Balance sheet total 2022: € 1,804,779 First fiscal year in the series	€ 1,731,645 Balance sheet total 2023: € 1,731,645 ▼ 4% vs 2022 (€ 1,804,779) Unchanged	€ 1,648,855 Balance sheet total 2024: € 1,648,855 ▼ 5% vs 2023 (€ 1,731,645) Unchanged	€ 1,692,501 Balance sheet total 2025: € 1,692,501 ▲ 3% vs 2024 (€ 1,648,855) Unchanged	▲ 3%
Employees (FTE)	3.5 Employees (FTE) 2022: 3.5 First fiscal year in the series	3.5 Employees (FTE) 2023: 3.5 Unchanged (3.5) Unchanged	3.5 Employees (FTE) 2024: 3.5 Unchanged (3.5) Unchanged	3.2 Employees (FTE) 2025: 3.2 ▼ 0.3 vs 2024 (3.5) Unchanged	▼ 0.3

Key figures of MEDI - PREST, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDI - PREST?

What happened at MEDI - PREST in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 19, 2026 New annual accounts for financial year 2025: profit of € 163,021 (▼ 4% vs 2024). Source: NBB ↗
2016 ADV PHARMA SRL became a director. NBB
2016 CAROLINE DE VRIESE became a director. NBB
Aug 7, 2006 New establishment in Enghien. KBO
Jul 29, 1991 Start of the company according to the CBE. KBO

In short

From € 202,485 profit in 2022 to € 163,021 profit in 2025.

Paid € 98,603 in corporate taxes since 2022.

Best year ever: 2023, with € 246,638 profit.

On average € 164,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

ADV Pharma 100%

The stake of ADV Pharma comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

MEDI - PREST

Behind MEDI - PREST are ADV PHARMA SRL and CAROLINE DE VRIESE. The shares are held by ADV Pharma (100%).

Directors

According to the 2025 annual accounts

ADV PHARMA SRL

Managing director · represented by ALINE DE VRIESE

Also active at: LA PHARMACIE DE VRIESE, La Pharmacie de Saintes, BAUPHAR

since 2016

CAROLINE DE VRIESE

Managing director

Also active at: LA PHARMACIE DE VRIESE, ADV Pharma, La Pharmacie de Saintes, BAUPHAR

since 2016

Shareholders

ADV Pharma

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Brusselsesteenweg(P.E.) 343

7850 Enghien

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0444.790.728

VAT number

BE 0444.790.728

Registered office

Brusselsesteenweg(P.E.) 343, 7850 Enghien

Names & denominations

MEDI - PREST

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

29 July 1991

Peppol

Active · Active since 10 Dec 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Groothandel in parfumerieën en cosmetica

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDI - PREST

Warning lights

Financials

What happened to MEDI - PREST?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions